What’s happening at Axsome Therapeutics, Inc. (NasdaqGM:AXSM)? What made the stock one of the top performing stock today? The company is indeed among the top gainers of the stock market, skyrocketing 10.62% (or 8.60 points) to $89.57 from its previous close of $80.97. So is it the right moment to buy?
The shares had a decreased trading volume of 2,381,967 contracts this session compared to the average daily volume of last 10 days of 2,610,400 contracts and they had an increased trading volume compared to the average daily volume of last 3 months of 1,297,218 contracts.
The indicator of a company’s profitability, the earnings per share ratio is -1.62. This value shows how much money a company makes for each share of its stock. A higher EPS indicates more value because investors will pay more for a company with higher profits. This is negative and tells you exactly how much money the company lost per share of its 34.5M outstanding stock.
The closing market price for this trading session was 4,517.01% over 52 weeks minimum price of $1.94 and 0.08% under 52 weeks maximum price of $89.64. Also the price is 223.17% greater than 200 day average of $27.72 and 132.95% greater than 50 day average of $38.45.
Latest news that might have contributed to the great perfomance of AXSM today are:
- Axsome Therapeutics Announces Proposed Public Offering of Common Stock, published on Wed, 18 Dec 2019 21:01:10 +0000
- The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO, published on Tue, 17 Dec 2019 12:56:25 +0000
- Axsome Therapeutics Added to NASDAQ Biotechnology Index, published on Tue, 17 Dec 2019 12:00:10 +0000